         id.exposure   id.outcome                                            outcome
1 met-d-Acetoacetate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
2 met-d-Acetoacetate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
3 met-d-Acetoacetate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
4 met-d-Acetoacetate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
5 met-d-Acetoacetate finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
                               exposure                    method nsnp          b        se
1 Acetoacetate || id:met-d-Acetoacetate                  MR Egger    7 -0.5044815 1.7199858
2 Acetoacetate || id:met-d-Acetoacetate           Weighted median    7 -0.6623326 0.6285293
3 Acetoacetate || id:met-d-Acetoacetate Inverse variance weighted    7 -0.6589296 0.5037849
4 Acetoacetate || id:met-d-Acetoacetate               Simple mode    7 -0.8803517 0.7854529
5 Acetoacetate || id:met-d-Acetoacetate             Weighted mode    7 -0.6968124 0.7708574
       pval
1 0.7810723
2 0.2919829
3 0.1908875
4 0.3052104
5 0.4008603
